p63 expression is consistently expressed in squamous cell carcinoma in the lung, but is also expressed in a subset of adenocarcinomas and large cell carcinomas.

rarity of p63 expression supports a nonbronchial histogenesis of bronchioloalveolar carcinoma, well-differentiated adenocarcinoma of lung, adenomatous hyperplasia and atypical adenomatous hyperplasia

p63 immunocytochemistry may be used in pulmonary cytologic samples of nonsmall cell carcinomas to identify squamous differentiation

the percentage of lung carcinoma patients remaining unclassifiable by TTF-1/TP63 was twice that of the five-antibody (TRIM29, CEACAM5, SLC7A5, MUC1, and CK5/6) test

Single nucleotide polymorphism in TP63 is associated with lung adenocarcinoma.

co-expression with TTF-1 protein in lung signet-ring cell carcinoma

High deltaNp63 expression is associated with squamous carcinoma than in adenocarcinoma of the lung.

Immunohistochemical staining using a combination of TTF-1, napsin A, p63, and CK5/6 allows subclassification of poorly differentiated non-small cell carcinomas on small lung biopsies in most cases.

p63 and p73 altered N-terminally truncated:transactivation domain expression ratio is associated with non-small cell lung cancer.

These findings show TP63 variation is a risk factor for the development of lung adenocarcinoma in the UK population

These findings strongly support the routine use of p40 in place of p63 for the diagnosis of pulmonary squamous cell carcinoma.

The tumor marker p40 appears to be a more reliable marker for squamous cell carcinoma than for lung adenocarcinoma.

findings provide strong evidence that genetic variation in TP63 is associated with the risk of lung adenocarcinoma among Asian females in the absence of tobacco smoking

we review the physiological and pathological role of p63 isoforms as well as their use as diagnostic markers in lung squamous cell carcinoma

Negative expression of RASSF1A was associated with non-small cell lung cancer.

To provide greater diagnostic accuracy, p40 (DeltaNp63) or keratin 34betaE12 should be used instead of p63 in the distinction of small cell lung carcinoma from non-small cell lung carcinoma in biopsy samples.

Our results suggest that genetic variation in TP63 may influence lung cancer susceptibility in the Han population

Report high frequency of coexpression of maspin and p63, as well as maspin and p53, in squamous cell carcinoma of the lung.

TP63 polymorphism might be a genetic susceptibility factor for lung adenocarcinoma.

TP63 gene polymorphisms are associated with lung cancer risk.

this is the first report of chromosomal rearrangements of TP63 in lung cancer, specifically in lung adenocarcinoma

TP63 polymorphisms rs10937405 and rs4488809 are a risk factor associated with increased non-small cell lung cancer susceptibility, particularly for East Asian populations. [Meta-analysis]

DeltaNp63-CYGB axis is also present in lung and breast cancer cell lines, indicating that CYGB-mediated ROS-scavenging activity may also have a role in epithelial tumours

Suggest p63 is a reliable marker in non-small cell lung carcinoma and can be used in differential diagnosis.

The immunocytochemical expressions of napsin A and p40 in imprint cytology seem to be of great utility for the accurate histological differentiation of lung cancers.

Immunohistochemical detection of thyroid transcription factor 1, Napsin A, and P40 fragment of TP63 can be used in the subclassification of non-small cell lung carcinomas.

polymorphisms in the TP63 and CD40 genes are associated with lung cancer in a Chinese Han population

Results suggest that TP63 rs7631358 G > A and CSF1R rs10079250 A > G may affect the risk and prognosis of lung cancer in never-smoking females.

Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine.

Immunohistochemical Detection of p40 expression in lung cancer Clinical Samples.